Anti-EpCAM Magnetic Beads-IP Kit Product Components
| Components | Storage |
| Anti-EpCAM Magnetic Beads1,3 | 2-8℃ for 12 months |
| NP40 Cell Lysis Buffer2 | -20℃ for 12 months |
| 5×TBST（pH7.4） | |
| 1×TBST（pH7.4） | |
| ddH2O | |
| CD166 Positive Cell Lysate | -20℃ for 12 months |
| Alkaline Elution Buffer | 2-8℃ for 12 months |
| Acidity Elution Buffer | 2-8℃ for 12 months |
| Neutralization Buffer | 2-8℃ for 12 months |
[1] The IP KIT contains anti-EpCAM magnetic Beads (2 mg/mL) in phosphate buffered saline (PBS, pH 7.4) with sodium azide (0.1%).
[2] Using NP-40 cell lysate buffer in the kit is required,otherwise,the magnetic beads may be precipitated.
[3] Shipping: Magnetic Beads kits are shipped at ambient temperature in which magnetic beads are provided in liquid buffer.
Anti-EpCAM Magnetic Beads-IP Kit Product Description
The Anti-EpCAM magnetic Beads, conjugated with Anti-EpCAM antibody, are used for immuneprecipitation (IP) of EpCAM proteins which expressed in vitro expression systems. For IP, the beads are added to a sample containing EpCAM proteins to form a bead-protein complex. The complex is removed from the solution manually using a magnetic separator. The bound EpCAM proteins are dissociated from the magnetic beads using an elution buffer. Anti-EpCAM Magnetic Beads-IP Kit Antibody Information
Immunogen
Recombinant Cynomolgus EpCAM / TROP-1 / TACSTD1 protein (Catalog#90299-CCCH)
Species Reactivity
Cynomolgus EpCAM / TROP-1 / TA
Source
Polyclonal Cynomolgus Rabbit IgG
Preparation
Produced in rabbits immunized with purified, recombinant Cynomolgus EpCAM / TROP-1 / TACSTD1 (rh EpCAM / TROP-1 / TACSTD1; Catalog#90299-CCCH; EHH55554.1; Met1-Lys265). EpCAM / TROP-1 / TACSTD1 specific IgG was purified by Cynomolgus EpCAM / TROP-1 / TACSTD1 affinity chromatography.
Applications
Immunoprecipitation (IP), Minimum Protein Purification
EpCAM Background Information
Epithelial Cell Adhesion Molecule (EpCAM), also known as GA733-2 antigen, is a type â… transmembrane glycoprotein composed of an extracellular domain with two EGF-Like repeats and a cystenin-rich region, a transmembrane domain and a cytoplasmic domain. It modulates cell adhesion and proliferation. Its overexpression has been detected in many epithelial tumours and has been associated with high stage, high grade and a worse survival in some tumour types. EpCAM has been shown to function as a calcium-independent homophilic cell adhesion molecule that does not exhibit any obvious relationship to the four known cell adhesion molecule superfamilies. However, recent insights have revealed that EpCAM participates in not only cell adhesion, but also in proliferation, migration and differentiation of cells. In addition, recent study revealed that EpCAM is the Wnt-beta-catenin signaling target gene and may be used to facilitate prognosis. It has oncogenic potential and is activated by release of its intracellular domain, which can signal into the cell nucleus by engagement of elements of the wnt pathway.
Immune Checkpoint Immunotherapy Cancer Immunotherapy Targeted Therapy Full Name
epithelial cell adhesion molecule
References
Brunner A, et al. (2008) EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder. J Clin Pathol. 61(3):307-10. Trzpis M, et al. (2008) EpCAM in morphogenesis. Front Biosci. 13: 5050-5. Munz M, et al. (2009) The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 69(14): 5627-9. Carpenter G, et al. (2009) EpCAM: another surface-to-nucleus missile. Cancer Cell. 15(3): 165-6.
新浪微博
腾讯微博
QQ空间
客服
